Furthermore, IL-6 downstream effects also modulate the activity of neutrophils, natural killer cells, or T cells, resulting in a decreased immune response to the neoplasm, despite the apparent trafficking of these immune cells to the lesion. The gene discussed is IL6; the disease is neoplasm.